Installing the LED Photocalorimeter Accessory for the Discovery DSC
Overview In this Tech Tip, we will install the new Phot…
Details
候選原料選定後的配方最佳化
藥物開發是個漫長而複雜的過程，從探索開始，一直到讓政府批准上市才算成功。如下所述，藥物開發過程中的每個步驟都有特定的目標，旨在篩選出適合的活性化合物和候選原料，最終得到已核准的原料藥。
Details
TA Instruments 快速篩選差示掃描量熱儀產品視頻
The RS-DSC is for preclinical development of antibodies, antibody-drug conjugates, and vaccines where dosage forms are typically greater than 50 µg.
Details
TAM Assistant – The Battery Cycler Microcalorimeter Solution
The Battery Cycler Microcalorimeter solution is an end-to-end, in-operando measurement tool for elucidating the thermodynamic and electrochemical details of battery cells in real time, in a flexible and intuitive system.
Details
印刷電路板 (PCB) 的熱分析
Printed circuit boards (PCBs) form the backbone of virtually all electronic applications. Enhancing their performance and reliability is paramount for custom PCB projects, where smaller footprints and improved maintainability lead to enhanced functionality.
Details
How to Assess Binding in Drug Discovery
The most popular tool used to characterize binding in the late-discovery phase of drug development is isothermal titration calorimetry (ITC). ITC is a high-resolution method for complete characterization of the basic chemical details of a binding interaction. The calorimeters accomplish this by measuring the heat that is released or absorbed when molecules interact with each other.
Details
4 Polymer Insights from Dynamic Mechanical Analysis
From material selection and failure analysis to end-use application, Dynamic Mechanical Analysis (DMA) offers crucial polymer insights. Polymer scientists and design engineers pair DMA with fatigue testing to gain a complete view of their material’s properties and performance attributes.
Details
生物製藥藥物開發工作流程和技術
Drug development is a long and complex process that starts with discovery and, if successful, ends with government approval for marketing. Each step in the drug development process, outlined below, has specific goals with the aim of down-selecting appropriate hits and candidates to an approved drug substance.
Details
